Ameriprise’s Crescent Capital BDC CCAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-28,843
Closed -$405K 4085
2025
Q4
$405K Sell
28,843
-60,454
-68% -$859K ﹤0.01% 3703
2025
Q3
$1.27M Buy
89,297
+270
+0.3% +$4.04K ﹤0.01% 3238
2025
Q2
$1.14M Buy
89,027
+8,518
+11% +$131K ﹤0.01% 3213
2025
Q1
$1.38M Buy
80,509
+10,374
+15% +$193K ﹤0.01% 3077
2024
Q4
$1.35M Buy
70,135
+4,706
+7% +$88.9K ﹤0.01% 3109
2024
Q3
$1.21M Buy
65,429
+2,305
+4% +$42.8K ﹤0.01% 3135
2024
Q2
$1.19M Buy
63,124
+8,229
+15% +$147K ﹤0.01% 3089
2024
Q1
$943K Buy
54,895
+33,548
+157% +$564K ﹤0.01% 3186
2023
Q4
$371K Buy
21,347
+1,589
+8% +$26.4K ﹤0.01% 3555
2023
Q3
$338K Buy
19,758
+4,507
+30% +$74.6K ﹤0.01% 3553
2023
Q2
$231K Buy
+15,251
New +$214K ﹤0.01% 3689

Other funds holding CCAP

Ameriprise's CCAP Position: Q1 2026 in Review

Ameriprise sold out of Crescent Capital BDC (CCAP) in Q1 2026, closing a stake of 28,843 shares — an estimated $405K sold.

Ameriprise first reported a position in CCAP in Q2 2023 and held it in 11 quarters. The position peaked at $1.38M in Q1 2025. 85 funds tracked by Wall St. Rank hold CCAP as of Q1 2026.

  • Ameriprise reported no remaining Crescent Capital BDC position as of Q1 2026 after selling out during the quarter.
  • Ameriprise sold 28,843 Crescent Capital BDC shares in Q1 2026, an estimated $405K.
  • Ameriprise first reported a position in Crescent Capital BDC in Q2 2023 and held it in 11 quarters.
  • Ameriprise's Crescent Capital BDC position peaked at $1.38M in Q1 2025.
  • 85 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.